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Abstract 
This doctoral project concern the preparation, the characterization, and the biological 
testing of a drug delivery system based on decorated carbon nanotubes aimed to 
the transport an anticancer drug inside cancer cells. Multi-walled carbon nanotubes 
have been modified to deliver doxorubicin inside cancer cells, resulting in an 
enhanced chemotherapic effect respect to the free drug. Decoration of the carbon 
nanotubes was accomplished through both covalent and non-covalent approaches: 
versatile click reactions and π-π interactions were exploited. 
To assess the internalization of the carbon nanotubes inside cells, a decoration with 
a fluorescent molecule, namely BODIPY, was performed. Next, the nanotubes were 
decorated with a selector molecule, biotin, to increase the uptake of the system by 
cancer cells. A representation of the system is depicted below (Figure 1). 
 
Figure 1. Schematic representation of the nanotube completely decorated. 
The non-toxicity of the simple delivery system alone (without drug) as well as 
the role of the selector have been investigated by parallel biological tests. Finally, the 
decorated system was loaded with the drug: doxorubicin. Comparative studies were 
performed on the loaded drug delivery system to highlight its effect respect to the 
free drug and to mark the role of the selector in the internalization efficiency.  
The overall project is composed by two parts: a) a comprehensive study of synthesis 
and characterization on the fluorescent probes suitable for the decoration of carbon 
nanotubes, with preliminary biological tests, and b) modification of carbon 
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nanotubes and their decoration with a selector and the drug. The second part was 
complemented by extensive biological tests.  
In the first part boron dipyrromethene complexes (BODIPY) were synthesized and 
fully characterized, giving a series of novel fluorescent probes able to cover a large 
part of the absorption and emission visible spectra. Fluorescent molecules were also 
equipped with functional groups for the decoration of the nanotubes. The biological 
tests performed confirmed that the fluorescent nanotubes were easily located inside 
different model cancer cells. The biological data on internalization were obtained 
through confocal microscopy analysis and cytofluorimetric tests.  
In the second part, the drug delivery system has been completed with biotin as 
selector molecule and with doxorubicin. Finally, the system was tested again in vitro 
on breast cancer cells MCF-7 and in vivo on nude mice xenograft model. In both 
cases comparative assays have been carried out with free doxorubicin, providing 
remarkable results. The adoption of biotin-decorated carbon nanotubes as vector to 
boost the drug internalization process, has resulted into increasing the 
chemotherapic efficiency of doxorubicin, both in cellular models and animal models. 
 
Appendix  
During the work, there has been the opportunity to further exploit the acquired 
knowledge on florescent molecules and on carbon nanotubes. This has resulted 
positively in two studies: the synthesis of a BODIPY-type molecule as component of 
a Molecular Dyad (appendix A), and a study on a different way to decorate carbon 
nanotubes for the engineering of carbon-based nanostructures (appendix B). 
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Part one - Azido substituted BODIPY dyes for the production of 
fluorescent carbon nanotubes 
 
As first step of the development of a carbon nanotubes (CNTs) based drug delivery 
system, we have synthesized carbon nanotubes decorated with fluorescent molecules 
(Figure 2). In a drug delivery system is necessary the presence of a fluorescent probe 
to study, by cytofluorimetric and imaging analysis, its internalization inside the cells. 
 
Figure 2. General scheme; the fluorescent decoration on nanotubes is the first step 
of the project. 
Concerning the fluorescent molecule, we have synthesized and characterized new 
derivatives of a class of fluorescent molecules known as BODIPY. The stability and 
the high fluorescence of these molecules are proven, as well as the tunability of their 
absorption and fluorescence wavelengths. Various BODIPY probes have been tested, 
and as carbon nanotubes we have adopted oxidized multiwalled carbon nanotubes. 
The functionalization of the nanotubes surface was performed through a covalent 
approach summarised in 3 steps: (i) the CNTs were preliminary functionalized with 
an azido function, (ii) the proper BODIPY and the biotin derivatives, bearing an alkyne 
function, were synthesized, (iii) the coupling between the CNT and the alkyne 
molecules was obtained through a simple "click" reaction. The CNTs have been 
characterized by spectrofluorimetric analysis, and their internalization inside cells was 
6 
evaluated by confocal microscopies and cytofluorimetric studies. Initial data of their 
cytotoxicity were also collected. 
In this first part of the work a series of azido-dyes have been synthesized 
through Knoevenagel reactions of an azido-BODIPY with aromatic aldehydes. The 
nature of the substituents allowed a fine tuning of their spectroscopic properties. The 
dyes were used to decorate oxidized multiwalled carbon nanotubes (ox-MWCNTs), 
bearing terminal triple bond groups, via CuAAC reactions affording fluorescent 
materials. This decoration allowed the efficient determination of the internalization 
of the ox-MWCNTs derivatives by different model cancer cells. 
 
1.1 Introduction on BODIPY fluorophores 
 
 
Figure 3. The core structure of BODIPY with the position. 
BODIPY type molecules (Figure 3) have found a widespread application as fluorescent 
probes.1 The chemical stability of the BODIPY core goes along with its synthetic 
versatility.2 The various reviews on the subject propose a large number of different 
structures.3,4,5 Such structural variety allows the coverage of a great part of the UV-
visible spectrum, both in absorption and emission. However, despite their wide 
applications, BODIPY probes have been used sparingly with nanostructured 
carbonaceous materials.6,7,8 In our ongoing study for the production of drug delivery 
systems based on CNTs9,10 it was chosen to decorate oxidized multiwalled carbon 
nanotubes, bearing terminal alkyne groups, with a fluorescent probe through a 
simple CuAAC reaction.11 The choice for the use of MWCNTs is related, among other 
more practical reasons (cost, easy control of oxidation) to their higher dispersibility 
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and suitability in biological applications. For this goal, it was necessary to synthesize 
simple dyes, bearing an azido group, whose absorption and emission properties 
could be finely modulated to fulfill the requirements for the detection during 
biological tests. In this part of the work it is described the synthesis of azido-
substituted BODIPY dyes in which the reactivity of the methyl groups present on the 
pyrrole rings is exploited in a series of Knoevenagel reactions to extend the 
conjugation of the core and to obtain derivatives whose spectroscopic properties 
were modulated by the nature of the substituents. This synthetic approach is a 
straightforward way of extending the molecular conjugation of the BODIPY 
dye,12,13,14,15,16,17 and is applied on azido-substituted BODIPY dyes for the first time. 
The availability of a library of BODIPY dyes bearing an azido group adds a useful 
alternative for their application in medicinal18,19 and material chemistry20 and, in our 
case, revealed to be a practical tool for the easy decoration of ox-MWCNTs. The 
coupling of properly modified ox-MWCNTs with BODIPY dyes afforded fluorescent 
material whose internalization inside cells has been monitored through 
cytofluorimetry and confocal microscopy analyses. 
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1.2 Results and Discussion 
The starting material is represented by the BODIPY dye 5, whose synthesis is already 
described.21 Compound 5 is easily obtained from 2,4-dimethylpyrrole (2) and 4-
nitrobenzaldehyde (3). Among the several different procedure reported in the 
literature we found more convenient to use the mechanochemical approach22 up to 
the intermediate 3 while the treatment with BF3·Et2O was performed in dry CH2Cl2.21 
The reduction of the nitro group with Fe powder/HCl afforded the corresponding 
amino group23 and the final conversion into the azido derivative 5 was performed 
with TMS-N3 and isoamyl nitrite (Figure 4).24 
 
Figure 4. Synthesis of the various BODIPY derivatives. Compound 5 and its 
transformation into azido-substituted dyes 7a-d and 8b-c. 
The reactivity of the two methyl groups in position 3 and 5 of the BODIPY core 
allowed to perform the Knoevenagel reaction with four different aromatic aldehydes, 
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6a-d, to afford the corresponding mono- and disubstituted derivatives (Figure 4). 
Previous examples of Knoevenagel reaction on BODIPY derivatives were performed 
treating the dye with an excess of aromatic aldehyde in the presence of acetic acid 
and pyrrolidine in refluxing toluene25 or in absolute ethanol.26 
However, the presence of the azido group on compound 5 made it sensitive to 
prolonged heating and required a compromise between conversion of the starting 
material and the final yields of the adducts. Even after a short reflux in toluene, the 
crude reaction material showed the presence of compounds in which the azido group 
had been lost. The best reaction conditions revealed to be reflux in MeCN for very 
short time, checking the reaction mixture by TLC. The results are reported in Figure 
4. The reaction conditions were not optimized for the synthesis of the double or 
mono substituted derivatives but for the obtainment, when possible, of both 
compounds. This choice was due to the need to explore the potentiality of these 
compounds to cover a large part of the visible spectrum, in absorption as well as in 
emission. The reaction with benzaldehyde (6a) and 4-HO2C-benzoic acid (6d) 
afforded exclusively the doubly substituted compound 7a24 and 7d, respectively, 
while 4-hydroxybenzaldehyde (6b) and pyridine-2-carbaldehyde (6c) afforded a 
mixture of mono- and disubstituted compounds (Figure 4). The structure of the final 
compounds were easily determined by 1H NMR spectroscopy showing the signals of 
the AX system related to the newly formed E double bonds. 
In line with our expectation, the absorption spectra (Figure 5) covered a wide 
part of the visible spectrum ranging from 500 to 650 nm. For the sake of clarity, the 
UV spectra of the dyes were normalized. The molar attenuation coefficients of the 
compounds are reported.  
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Figure 5. Absorption spectra (normalized) of compounds, 5, 7b, 8b, 8c (DMF), 7d 
(H2O/DMF) and 7a, 7c (CH2Cl2). 
Compound UVmax (nm) solvent ε (M-1 cm-1) 
5 503 DMF 7.5 103 






641 CH2Cl2 6.8 104 
652 DMF 6.5 104 




570 CH2Cl2 9.9 103 
576 DMF 8.7 103 
7c 624 CH2Cl2 3.2 105 
8c 
560 CH2Cl2 2.0 105 
560 DMF 1.1 105 
7d 633 H2O/DMF 3.7 103 
Table 1. UVmax and molar attenuation coefficient (ε) of compound 5, 7 and 8. 
Table 1 shows also a remarkable solvatochromic effect. Compound 7b, sufficiently 
soluble in water, showed a 32 nm red shift moving from CH2Cl2 to H2O. 
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Also the maxima (see Figure 6) in the emission spectra were scattered, covering a 
range of 150 nm. The Stokes shift values are very low as usually happens with this 
kind of fluorescent dyes, ranging from 8 nm (compound 8c) to 18 nm (compound 
7c).5 
 
Figure 6. Emission spectra (normalized) of compounds 5, 7b, 8b, 8c (DMF), 7d 
(H2O/DMF) and 7a, 7c (CH2Cl2). 
The presence of the azido group on all the substituents allows their use in CuAAC 
reactions with compounds bearing a terminal triple bond. This reactivity was used for 
the decoration of ox-MWCNTs 9 bearing terminal triple bonds (for the synthesis and 
characterization see experimental section, and from Figure 33 to Figure 39).27,28,29 The 
CuAAC reaction with dyes 5, 7b and 8c was performed in DMF and afforded the 
fluorescent ox-MWCNTs derivatives 10-12 (Figure 7). The decoration of the MWCNTs 
afforded fluorescent materials whose absorption and emission properties can be 
easily tuned using differently substituted BODIPY dyes. This material revealed stable 




Figure 7. The CuAAc reaction between CNTs 9 and BODIPY dyes 5, 7b and 8c. 
Figure 8 and Figure 9 show the absorption and emission spectra of compound 10-
12. The decoration of the CNTs walls did not alter significantly the absorption and 
the emission maxima of the BODIPY derivatives. This appears evident comparing the 
UV and fluorescence maxima of compounds 5 and 7b with those of 10 and 12, 
respectively: the wavelengths of absorption and emission (measured in DMF) are the 
same for each sample. This might be rationalized considering that the fluorescent 
probe is efficiently solvated by DMF reducing to a minimum the interaction with the 
CNTs. On the contrary, compound 8c shifted its UV and fluorescence maxima by 11 
and 22 nm, respectively, when anchored to ox-MWCNTs to give compound 11. This 
might be due to the presence of a pyridine ring on the dye and its interaction with 
the carboxylic groups present on the ox-MWCNTs 
13 
 
Figure 8. Absorption spectra of compounds 10-12. All spectra are registered in DMF 
(0.05 mg/mL). 
A main issue, working with CNTs, is the determination of their functionalization 
degree obtained after a reaction. Very often this information is obtained through 
elemental or thermogravimetric analysis. 
 
Figure 9. Emission spectra (normalized) of compounds 10-12. All spectra are 
registered in DMF (0.05 mg/mL). 
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The presence of the BODIPY dyes, bearing a boron atom, allowed the use of 
inductively coupled plasma atomic emission spectroscopy (ICP-AES) for a 
quantitative determination of the functionalization degree of decorated 
ox-MWCNTs. In the case of compound 10 the analysis revealed a presence of 12.4 
mg of Boron per gram of material (1.14 mmol/g of material) while for compound 11 
the analysis revealed the presence of 6.2 mg per gram of material (0.57 mmol/g of 
material). The certification of the capacity of the fluorescent probes to show the 
internalization of CNTs inside cancer cells was granted by a series of cytofluorimetric 
analyses performed on three different cancer cell lines: MCF-7 (human breast 
adenocarcinoma), PC3 (prostatic small cell carcinoma) and HT29 (human colon 
cancer) after incubation ,with compound 10, 11 and 12 (Figure 10 and Table 2). 
 
Figure 10. Cytofluorimetric analysis of MCF-7 cell lines after incubation with 
fluorescent CNTs: a) control experiment, b) incubation with 10, c) incubation with 
11, d) incubation with 12 
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Figure 10 shows the results of three cytofluorimetric analyses performed with 
compounds 10-12 on MCF-7 cancer cell lines. The figure show the remarkable 
increase of fluorescence of the cells, directly related to the internalization of the CNTs. 
Table 2 resumes all the cytofluorimetric data collected for the three different cancer 
cell lines. In all cases there is a net increase of the cellular fluorescence demonstrating 
that the decorated carbon nanotubes are efficiently internalized by different cell 
lines.30 While it is not possible to compare the internalization degree of the different 
compounds inside one kind of cell cultures, since any enhancement or quenching 
effect might be different, it is possible to compare the difference between the 
internalization degrees of the same compound inside different kind of cells. For 
example MCF-7 cells showed a much higher fluorescence when incubated with 10 
respect to HT29 and PC3 (5-fold the final fluorescence value). The opposite holds for 
12 for which HT29 and PC3 cells showed a 3-fold value of the final fluorescence. Since 
the functionalization degree of the compound used is the same, it is possible to 
correlate, at least qualitatively, the degree of internalization with the enhancement 
of fluorescence. 
Table 2. Fluorescence data from cytofluorimetry analysis after incubation of three 
different cell lines with compounds 10-12.a 
Cell line 
10 11 12 
Control Treated Control Treated Control Treated 
HT29 136 597 344 4190 69 1350 
PC3 93 531 247 4879 158 1260 
MCF-7 180 2650 275 1380 275 2900 
a Each cell culture was incubated for 90 min with a water dispersion of the decorated nanotubes 10-11 (10 
µg/mL). Data reported in the table, represent the mean values of the fluorescence of the cells. 
Finally, compound 11 was used in a confocal microscopy analysis performed on 




Figure 11 images of a MCF-7 cell culture after incubation with MWCNTs 11. 
Compound 11 has been chosen since it best fitted the excitation frequency (571 nm) 
of the laser used in the confocal microscopy analysis. Despite MCF-7 cells were those 
that evidenced the smaller increase in fluorescence upon incubation with compound 
11, the confocal analysis afforded clear pictures (Figure 11): the fluorescence of 
compound 11 is well distributed in the cytoplasm of the cells while the nuclei remain 
unaffected. Concerning the amount of material internalized, during the biological 
tests it was not possible to determine any difference between the cell cultures 
incubated with simple ox-MWCNTs and those incubated with compound 11. 
 
1.3 Toxicity tests 
To verify any possible toxic effect of the nanostructured materials, MTT vitality assays 
have been performed and the results are reported in Figure 12 (for details on MTT 
assay see experimental section). MCF-7 breast cancer cells were incubated for 24 
hours in the presence of 10 µg/mL of compound 11 or 10 µg/mL of ox-MWCNTs, 
after this time, viability of cells was evaluated using MMT assay. 
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Figure 12. MTT test. The data report the cell survival rate (%) normalized with 
respect to control experiments. Data reported represent the mean value ± S.E.M. (n 
= 3). 
As it is clear, neither simple ox-MWCNTs nor compound 11 show any sign of 
cytotoxicity towards MCF-7 cell lines using a concentration of 10 mg/mL of the 
material. 
 
Conclusions of Part One 
A series of Knoevenagel reactions of an azido-BODIPY derivative allowed the 
production of a small library of azido-substituted fluorescent dyes whose 
spectroscopic properties are tuned by the nature of their substituents. The presence 
of an azido group on the fluorescent dyes allowed their easy anchoring onto properly 
substituted ox-MWCNTs. This affords fluorescently labeled nanostructured carbon 
materials that are internalized efficiently inside cells after a brief incubation time. This 
material can thus be easily exploited as platform for the selective delivery of drugs 
into cancer cells.  
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Part two - Decorated carbon nanotubes for the delivery of 
doxorubicin into cancer cells 
 
In the first part of the project, a series of azido-substituted BODIPY dyes have been 
developed and used for the decoration of ox-MWCNTs bearing terminal triple bonds 
on their surface. The material showed very good ability to penetrate the cellular 
membranes and has been proven to be not toxic towards cells. On the base of these 
results, the work has progressed with the further decoration of nanotubes to 
assembly the complete drug delivery system (Figure 13). To avoid the manipulation 
of small organic azides, we have reversed the functional groups involved in the 
“click”reaction, but without any observed change, nor in the reactivity, neither of 
biological activity of the compounds. As selector, to increase the uptake of the system 
by cells, biotin have been already tested as simple and general targeting molecule 
for cancer cells.31,32,33,34 Finally, the decoration with doxorubicin (DOX). This drug has 
become a common benchmark for the comparison of efficiency of drug delivery with 
CNTs. The system has been therefore subject to several tests in vitro to assess the 
biological activity.  
 
Figure 13. The complete drug delivery system into its components 
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The project has been thus completed with the realization of 
multiple-decorated ox-MWCNT as vectors able to carry doxorubicin inside breast 
MCF-7 cancer cells. The ox-MWCNT conjugated doxorubicin resulted in an enhanced 
cytotoxic effect with respect to the free drug. 
 
2.1 Overview on CNTs for the drug delivery 
The use of carbon nanotubes as carriers for antitumoral drugs has emerged, both in 
vitro and in vivo, as a valuable method for the treatment of tumors.35,36,37 The efficient, 
and non-selective, mechanism of internalization of functionalized CNTs by cells 
paved the way to the use of CNTs as drug carriers, but also rose severe concerns 
about their toxicity and lack of selectivity.38,30 Recent studies revealed that the toxicity 
of CNTs can be controlled by the functionalization of the walls, making them more 
hydrophilic and short, avoiding the formation of bundles.39 Meantime, the decoration 
of functionalized CNTs with efficient selectors for receptors, expressed on the surface 
of target cells, afforded selectivity required to propose a modern and effective drug.40 
While the fluorescent probe and the selector were anchored through the “click on 
tubes” approach (covalent conjugation through the formation of triazole rings 
obtained with CuAAC reactions between azido substituted ox-MWCNTs and HCC- 
bearing molecules), the doxorubicin molecules were anchored via the formation of 
supramolecular complexes with the CNTs wall.41 Such synthetic approach is designed 
to be modular, allowing an easy variation of the fluorescent probe, selector and drug 
without redesigning the whole procedure. 
 
2.2 Result and discussion 
2.2.1 Preparation of the carbon nanotube support 
The starting materials for this second part of the work were the functionalized CNTs 
carrying the azido groups. In a reported study, a demonstrative feasibility of the 
synthesis of functionalized CNTs carrying the azido groups was carried out on 
single-walled CNTs.9 However, the use of ox-MWCNTs was kept for sake of continuity 
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as well as for the initially described reasons. Commercially available MWCNTs were 
oxidized by treatment with the sulphonitric mixture,29 and the resulting material 
results easily dispersible in water and polar solvents as DMF and DMSO. The 
ox-MWCNTs were, eventually, functionalized following the Tour42 protocol using 4-
azido-phenylamine (13), Figure 14. 
 
Figure 14: Functionalization of ox-MWCNTs through the Tour reaction. 
Compound 14 exhibited in a net and sharp absorption at 2100 cm-1 IR spectrum 
(Figure 40, experimental section) suggesting a high level of functionalization that was 
quantitatively determined through both Elemental Analysis and Thermo Gravimetric 
Analysis (TGA), (see Table 3 and experimental section). Furthermore, a CuAAC 
reaction of compound 14 with N-Boc propargylamine (15) to confirm the level of 
functionalization was performed (Figure 15). A TGA-Mass Spectrometer analysis of 
cycloaddition product 16 (TGA-MS, see experimental section, Figure 41), by 
measuring the amount of isobutene generated at high temperature from nanotubes 
16, made possible to evaluate also the yield of the click reaction. Collected data are 
summarized in Table 3. 
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Figure 15: CuAAC reaction of CNTs 14 with N-Boc protected propargylic amine. 
Compound 
N3 content (Elem. 
An.) mmol/g 
 N3 content 
 (TGA) mmol/g 
isobutene content 
(TGA) mmol/g 
14 2.06 2.13 - 
16 - - 2.13 
Table 3: Functionalization degree evaluated through Elemental Analysis and 
TGA of compounds 14 and 16. 
Both elemental and TGA analyses of compound 14 gave very close values of 
functionalization while the TGA analysis performed on 16 suggests that the 
conversion of the CuAAC reaction is quantitative. 
 
2.2.2 Decoration of carbon nanotubes 14 through CuAAC reactions 
Once obtained the functionalized platform the work focused on its decoration with 
the different building blocks needed for the production of the drug delivery system. 
The first step was the decoration of 14 with fluorescent probes 17 and 18, bearing a 
terminal triple bond, by cycloaddition onto the azido-CNT 14. The CuAAC reaction 
proceeded smoothly using CuI·P(OEt)3 as catalyst and afforded, the corresponding 
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fluorescent CNTs 19 and 20 (Figure 16). The same synthetic approach, using the 
propargyl biotin derivative 21, afforded biotinylated-CNT 22 (Figure 17).  
 
Figure 16. CuAAC reaction of CNTs 14 with BODIPY dyes 17 and 18. 
 
Figure 17. CuAAC reaction of ox-MWCNT 14 with biotin derivative 21. 
A doubly functionalized CNT, with a fluorescent probe and a selector, was 
synthesized using a 1:1 mixture of the biotin derivative 21 and either one of the 
BODIPY derivatives 17 and 18  (Figure 18).  
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Figure 18. CuAAC reaction of ox-MWCNT 14 with a 1:1 mixture of compounds 
17/21 or 18/21 to afford compounds 23 and 24, respectively. 
The presence of boron in the BODIPY derivatives, as well as sulphur in biotin, allowed 
the use of ICP-AES analyses to evaluate their content and the functionalization 











1 19 9.76 0.90 - - 
2 20 3.05 0.28 - - 
3 22 - - 4.26 0.13 
4 23 7.37 0.68 5.12 0.16 
5 24 0.99 0.09 1.55 0.05 
Table 4. Content of Boron and Sulphur of MWCNT 19, 20, 22, 23 and 24 by ICP-AES 
analysis. 
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The nanotubes 19, containing the BODIPY dye 17, showed a good level of loading, 
although lower that that obtained with nanotubes 16 (see Table 3). Likely the 
bulkiness of the BODIPY derivative hampers an efficient cycloaddition process. The 
trend of a decrease of loading is confirmed with the bulkier dye 18 and biotin 21 
(entries 2 and 3, Table 4). Regarding the doubly decorated compounds 23 and 24, 
whereas the functionalization degree is still relatively high for 23 (entry 4, Table 4), it 
becomes roughly ten times lower in the CNT 24 (entry 5, Table 4). Albeit a detailed 
study to maximize the loading of the material was not performed, simple variations 
of the reaction conditions did not afford a higher loading. Nevertheless, both 
compounds 23 and 24 revealed a sufficient loading useful for the biological tests 
(see below). 
The UV and fluorescence spectra, performed in DMF solution, confirmed the 
presence of the fluorescent dye on the CNTs walls of 19-24 (Figure 19).  
a  b 
c  d 
Figure 19. UV-Vis absorption (black) and fluorescence emission (red) spectra of 
compounds 19, 20, 23, 24, (respectively a, b, c, d) performed in DMF. 
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2.3 Biological tests 
A series of biological tests were performed to establish the internalization of the 
prepared nanotubes 19 and 20 by MCF-7 cells and, eventually, to measure the 
toxicity of the compounds. Cell cultures have been incubated with ox-MWCNT 19 
and 20 for 24h, and two cytofluorimetric analyses showed a net increase in the 
fluorescence (see experimental section). Furthermore, the uptake of ox-MWCNTs 20 
was then evaluated through confocal microscopy, and a good incorporation of 
fluorescent material inside the cytoplasm of cells was observed (see Figure 20). It still 
appreciable a sharp prevalence of the fluorescent material in the cytoplasm respect 
to the nucleus.  
  
Figure 20. Confocal images of a MCF-7 cell culture after incubation with CNTs 20. 
Two experiments have been conducted: with 5 µg/ml (left), and with 10 µg/ml of 
material (right). 
The synthetic approach used for the decoration of CNTs afforded highly fluorescent 
materials able to permeate efficiently the cellular membrane of the model tumor 
cells. To evaluate the influence of the biotin residues introduced on nanotubes 
towards the internalization process, the CNTs 19 and 23 were tested in two parallel 
experiments under the same conditions. After incubation, the cellular samples were 
washed repeatedly, counted, and lysed. Then, the respective amounts of boron of the 
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samples were evaluated through ICP-AES analysis (Table 5). As blank, an ICP analysis 
was also performed on a culture grown in absence of nanotubes. To obtain the 
average quantity of CNTs per cell has been taken in account the number of cells 
(around 106 cells) in the sample and the boron content per milligram of CNT.  
Data from ICP Compound 19 Compound 23 
Internalization ratio 
 23 : 19 
mg Boron/Cell 3.5·10-11 4.3·10-10 
16.9 
mg CNT/cell 4.03·10-9 6.8·10-8 
Table 5. ICP data show the boron content of lysed cells, the respective quantity of 
internalized CNTs 23 and 19. 
The data in Table 5 show the clear role of biotin in favoring the internalization 
process. Biotin and BODIPY decorated CNTs are internalized one order of magnitude 
better than simply BODIPY decorated CNTs. 
Once the internalization and the role of the selector was assessed, a series of toxicity 
tests were performed on nanotubes with BODIPY (19) and with both biotin and 
BODIPY (23) to evaluate the toxicity of the carrier system alone. MCF-7 cells were 
incubated in the presence of growing doses of nanotubes and analyzed through 
MMT assay to evaluate the cell viability. The results are reported in Figure 21 and 
show no appreciable decrease in the cellular viability.  
27 
  
Figure 21. MMT vitality assays of MCF-7 incubated with different concentration of 
nanotubes 19 and 23, no appreciable decrease in the cellular viability is observed. 
2.3.1 Loading of doxorubicin on the carrier. 
Once assessed that the decorated CNTs are non-toxic towards MCF-7 cells, biotin 
and BODIPY decorated CNTs were loaded with doxorubicin (DOX). The loading of 
DOX on carbon nanotubes was performed exploiting the π-stacking interaction 
between the aromatic surface of CNTs and the aromatic rings of doxorubicin. Stirring 
an aqueous dispersion of CNTs 24 and doxorubicin afforded the desired complex 25 
(see Figure 22). 
 
Figure 22. Loading of doxorubicin on biotin- BODIPY-decorated CNTs 24. 
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The grafting of doxorubicin on CNTs 24 is reversible and the equilibrium is strictly 
dependent from pH, since the protonation of the glycosidic amino group renders 
doxorubicin more hydrophilic. To ensure a good loading of drug on CNT and reduce 
the risk of decomposition of doxorubicin, likely in alkaline conditions,43 a phosphate 
buffered solution with a pH = 7.4 was used. To evaluate the efficiency of the loading 
reaction, after stirring overnight the doxorubicin and the CNTs dispersion, the 
phosphate buffer solution was filtered off and the solid material was washed 
repeatedly with new phosphate solution to remove the free drug. A sample of the 
solid filtrate was dispersed in a buffer solution and an UV-visible spectrum registered. 
From Figure 23 is clearly observable the presence of doxorubicin in the CNTs 25. 
 
 
Figure 23. UV-visible spectra of compound 25 (solid line), and 24 (dashed line). 
The quantitative data were then obtained through a calibration curve of doxorubicin 
in buffer solution. The DOX loading on nanotubes 25 is reported in Table 6, showing 
the large amount of drug attached on ox-MWCNTs compared to the quantity used 
for the loading reaction. 
 
 




















Load of DOX on nanotubes  
DOX/CNT (g/g) DOX attached 
0,60 90,6 % 
Table 6. Loading and percentage of DOX attached on MWCNT 25. The DOX 
attached is referred to the total amount of DOX added in the loading reaction. 
To monitor the release over time of doxorubicin from CNT, nanotubes were stirred 
for 120 h in a buffer solution, centrifuging and renewing periodically the solvent. The 
amount of drug released at each wash was measured, as before, by UV-visible 
analysis of the supernatant solution. The drug release profile was observed at two 
different pH: 7.4 and 5.3 (Figure 24), and the collected data are summarized in Table 
7.  
 
Figure 24. Release profiles of doxorubicin from CNTs 25 in buffer phosphate 
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 Release of DOX 
 g DOX released/g CNT DOX released/DOX loaded 
pH 7.4 0,16 13,2% 
pH 5.3 0,32 26,5% 
Table 7. Total value of doxorubicin released from CNTs 25. 
The two different profiles show the strict dependence of the complexation 
equilibrium on pH. Because it is known that cancer tissues show a higher level of 
acidity compared to normal tissues,44 very high acidity conditions were chosen to 
underline the pH-dependent detaching mechanism of doxorubicin from carbon 
nanotubes.  
The cytotoxicity of the DOX/BODIPY/biotin decorated carbon nanotubes, was 
then tested to measure the efficiency of the whole drug delivery system. Cells viability 
was assessed using the same protocol adopted for the carrier alone (see paragraph 
3.2) and compared with that of carrier without drug (Figure 25). 
 
Figure 25. The cytotoxic effect of the complete system (25) compared with the 
carrier without drug (24). 
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2.3.2 Final tests in vitro on the ultimate drug delivery system  
In the last step the fluorescent probe is no longer required and the system was 
evaluated directly in terms of cytotoxic efficiency. The final drug delivery system was 
compared with free doxorubicin and with an analogous without biotin to complete 
the investigations about the role of the selector. Biological experiments have been 
performed on CNTs functionalized only with biotin (CNT-biotin, compound 22, 
Figure 17), on CNTs functionalized with biotin and doxorubicin (CNT-biotin-DOX, 
compound 26), and on CNTs loaded only with doxorubicin (CNT-DOX, compound 
27). The biological tests were carried out in the same conditions of the previous 
(incubation time 24h). The preparation of these compounds as well as the details on 
the biological experiments are described in the experimental section. To homogenize 
the results, the quantity of sample incubated is weighted by the relative load of 
doxorubicin. The structures of 26 and 27 with the relative loads of DOX are depicted 
in Figure 26. The overall results are explicated in Figure 27. 
 
Figure 26. Structures of DOX decorated CNT with the relative load of doxorubicin. 
Data on cytotoxic efficiency are reported below.  
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Figure 27. The differences of cytotoxicity between CNT biotin-decorated and DOX 
loaded respect to simply MWCNT DOX loaded or free DOX.  
The data show clearly the increased cytotoxic effect of biotin-decorated nanotubes 
respect to the simple drug-loaded nanotubes, but also respect to free doxorubicin. 
In both comparisons, the major cytotoxic effect can be ascribed to the role of biotin-
decorated carbon nanotubes as vector in the drug internalization process. As blank, 
to ensure again the absence of toxicity of the system in absence of the drug, biotin-
MWCNT 22 was tested again. It is worth to be noted that delivery of doxorubicin 
through the CNT-biotin drug-delivery system reduces sensibly the amount of 
doxorubicin required for the same cytotoxic effect. Therefore, for the complete 
system 26, on the base of the data showed in Figure 27, a preliminary value of IC50 
can be estimated around 0.2 µg/ml. The cytotoxicity of this drug delivery system is 
higher than the drug alone, currently adopted for the tumor treatments; this is a 
positive result about the possibility to boost the cytotoxicity of doxorubicin by the 
use of carbon nanotubes as vectors. 
A last series of cytotoxicity test was performed on MCF-7 cancer cells to 
observe the effect of exposure to high concentration of product for a short time 
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(Figure 28). In this case, MCF-7 cells have been incubated with 50 µg/ml of substance 
for 1 hour, then washed, and let to grow in a normal culture medium. After 48 and 
72 hours, MTT vitality assays were performed as usually. 
 
Figure 28. Test of toxicity at high concentration of sample for short time, the 
conditions are the same for all samples: 50 µg/ml of substance for 1 hour of 
exposition. 
The results of this further series of tests show a behavior analogous to the previous 
test, confirming the trend of the toxicity previously observed.  
 
2.3.3 In vivo study 
On the base of the encouraging results so far obtained in vitro, the work has 
progressed with the biological tests in vivo. Tests have been performed on nude mice 
subcutaneously injected with MCF-7 cancer cells. 30 days after the injection, the 
tumor mass reached the dimension of 5 mm and the treatments have been started. 
The animals were divided in three groups and subjected, once a week, for 21 days, to 
a tail injection (200 µL/mouse) of the compounds. The first group was treated with 
CNT-biotin-DOX (compound 26), the second with pure DOX, and the third with CNT-




























by the relative load of doxorubicin, and amount to 5 mg of DOX per Kg of animal 
weight. The tumors sizes were measured with caliber every week and are reported in 
mm3 in Figure 29.  
 
Figure 29. Evolution of the tumor size according to the different treatments. 
At day 22 euthanasia have been performed and the tumors masses were excised and 
weighted. The results of the different treatments are reported in Figure 30 
(photography of the excised tumors) and Figure 31 (weight of the tumors). 
 
Figure 30. Photography of the tumors excised at day 22 of the treatment. The 
differences between the various treatments are appreciable. 
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Figure 31. Weight of the tumor masses according to the different treatments, 
(*) t -tests indicate significant differences between the experiments at p<0.05 
As can be observed from these pictures, the difference between tumors treated with 
DOX and tumors treated with the DOX on nanotubes 26 is easily appreciable. 
Immunohistochemistry assays were also performed on paraffin embedded tumors. 
The samples were stained with marker of proliferation Ki67 and with H&E 
(Figure 32); the microscopy images show the strong reduction in the proliferation of 




Figure 32. Paraffin embedded tumor tissue stained with H&E and Ki67 (bright field 
microscopy images). The lowest proliferation of cancer cells is clearly observable in 
the treatments with nanotubes-delivered doxorubicin (compound 26). 
 Summarizing the data obtained in vivo, a net increase of the drug effect was 
founded, confirming the positive results of the in vitro experiments.  
The mayor anticancer activity of the doxorubicin administrated through this drug 
delivery system respect to free drug was founded. This consolidate the way to 
improve the existing anticancer therapies by the use of modified carbon nanotubes 





A new level of cytotoxic efficiency was found for doxorubicin, respect to the free drug, 
adopting decorated multiwalled carbon nanotubes as drug delivery system. Although 
the literature flourishes with new examples of drug delivery system based on carbon 
nanotubes, a direct comparison of our data, related to the use of CNT, doxorubicin 
and MCF-7 cell lines, restrict the choice to few articles. In particular, a good 
comparison is offered by the extensive work by Jain45 and co-workers in which the 
authors reports the IC50 of several functionalized CNT loaded with doxorubicin 
towards MCF-7 cell lines. The IC50 values reported ranged from 5.6 to 0.6 µg/mL.  
In the present PhD work, Figure 27, shows that the plausible value of IC50 for 
this DOX drug delivery system, stands between 0.1 and 0.25 µg/mL. The in vivo study, 
although preliminary, confirms the good performances obtained and support the 
prosecution of the work. 
Finally, it should be stressed the simplicity of the approach: the oxidation of the 
MWCNTs and their derivatization with azido aniline afforded an easy tunable 
platform for further decorations. The materials obtained are easily dispersible in 
water and, when higher concentration are needed, in DMSO/Water. This kind of 
approach allows the covalent grafting of polar drugs (through simple modifications 
and CuAAC reaction) as well as the supramolecular complexation of hydrophobic 
drugs likes doxorubicin. Such activity is actually ongoing in our laboratories 
Summarizing the overall results of this PhD project, all the starting goals have 
been fulfilled: a new carbon nanotube-based drug delivery system was designed, 
developed, characterized and extensively tested. The biological tests showed positive 
results: a sharp increment of the chemotherapic effect of the drug was achieved. On 
the base of these solid data, the work has progressed with tests on animal models. 
The in vivo results have been conclusive too, confirming the data obtained in vitro; a 
significant reduction of the tumoral mass respect to the administration of the free 
drug was observed. These outcomes have evidenced the clear role of the drug 




Although a wide work of biological testing and chemical characterizations have been 
performed on the prepared drug delivery system, in the aim to obtain chances to 
develop such a pharmaceutical product, more stringent, and more extensive 
characterizations are required. For instance, concerning the biological aspect, an 
exhaustive study of the pharmacodynamics and pharmacokinetics must to be 
performed. On the other hand, a strict definition of all the chemical species involved 
- in terms of molecules, nanostructures, and supramolecular aggregates - is 
mandatory.  
The fulfillment of these aims means also to establish and consolidate a proof of 
concept about the working of the system. Once established the proof of concept, the 
developed system gains a high added value, since is proven its ability to work in a 
real biological environment. This allows to continue with more chances the drug 
development process and also to try, with more awareness, a proper tuning of the 
properties of the delivering platform developed, as well as to test other drugs to be 






3.1 Materials and methods 
All reagents, whose synthesis is not described, have been purchased and used, if not 
specified, without further purification. Compounds, 13,46 15,47 21,48 and BODIPY A22,23 
were synthesized according to respective literature procedures. The catalyst 
CuI•P(OEt)3 was synthesized according to ref.49 but using toluene as solvent instead 
of benzene. Multi walled carbon nanotubes were purchased from Sigma-Aldrich (Lot. 
n. MKBH7743V). Yields refer to chromatographically and spectroscopically pure 
compounds. Rf values, refer to silica gel plates (0.25 mm, Merck Silica gel 60 F254) or 
aluminum oxide gel plates (0.25 mm, Merck Aluminum oxide 150 F254) as specified, 
and obtained using the same eluent as in the separation of the compound by flash 
column chromatography. NMR spectra were recorded on a Varian Gemini 200 and 
on Varian Mercury 400 at room temperature. Chemical shifts (δ) were reported in 
parts per million (ppm) relative to residual solvent peaks rounded to the nearest 0.01 
for proton and 0.1 for carbon (reference: CHCl3 [1H: 7.26, 13C: 77.2], DMSO [1H: 2.50, 
13C: 39.5], CH3OH [1H: 3.35, 13C: 49.3]. Coupling constants (J) were reported in Hz to 
the nearest 0.1 Hz. Peak multiplicity was indicated as follows: s (singlet), d (doublet), 
t (triplet), q (quartet), m (multiplet) and br (broad). Thermogravimetric analyses (TGA) 
were performed under N2 atmosphere (50 mL min-1) on an EXSTAR 
thermogravimetric analyzer (TG/DTA) Seiko 6200 coupled with a ThermoStar GSD 
301T (TGA-MS) for MS analysis of volatiles. The ICP multielemental analysis were 
made using an Optima 2000 Perkin Elmer Inductively Coupled Plasma (ICP) Optical 
Emission Spectrophotometry Dual Vision after acid mineralization. MS Spectra were 
recorded using LCQ-Fleet Thermo Scientific Electron Spray Ionization (ESI); spectra 
were recorded on 10-4-10-5 M samples in HPLC grade MeOH. Infrared spectra were 
recorded on a Perkin-Elmer FT-IR 881 spectrometer. IR data are reported as 
frequencies in wavenumbers (cm-1). Elemental analyses were performed with a 
Perkin-Elmer 240 analyzer and a CHN-S Flash E1112 Thermofinnigan analyzer. UV-
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visible spectra were registered using a Varian Cary 4000 Uv-vis spectrophotometer 
using a 1 cm cuvette. Fluorescence spectra were registered using a FP750 
spectrofluorimeter using a 1 cm cuvette. UV and fluorescence spectra of the dyes 
were registered using a 10-5 M solution of the compound in the reported solvent. 
Centrifugations were performed on a Hettich Universal 320 centrifuge at 1400 g and 
on a Labnet 24D Spectrafuge at 15000g, for the time stated. 
 




Compound 5 was obtained with a multistep synthesis. Compound 3 was obtained 
following the mechanochemical procedure reported in reference 22. Compound 4 
was obtained following the procedure reported in reference 21. Transformation of 




indacene (7a). See reference 24. 
 
8-(4-Azidophenyl)-1,7-dimethyl-3,5-bis-[2-(4-phenolyl)ethenyl]-4,4-difluoro-4-




4-Azidophenyl-Bodipy (5) (80 mg, 0.22 mmol) and 4-hydroxybenzaldehyde (108 mg, 
0.88 mmol, 4 eq.) were dissolved in anhydrous CH3CN (10 mL), with pyrrolidine (109 
µL, 1.31 mmol, 6 eq.) and acetic acid (75 µL, 1.31 mmol, 6 eq.). Activated molecular 
sieves (4 Å, 200 mg) were added. The mixture was stirred at 80 °C under N2 
atmosphere. After few minutes a quick change in the color of the mixture is observed, 
from red to dark blue and TLC on silica (CH2Cl2/AcOEt 5:1), revealed the presence of 
a red spot (Rf = 0.83) and a blue one (Rf = 0.33). The reaction was monitored by TLC 
41 
and after 1 h was cooled to room temperature, filtered and the resulting solution 
diluted with AcOEt (50 mL). The organic phase was washed with aqueous HCl (3x50 
mL, 0.05 M), brine (100 mL), dried over anhydrous Na2SO4, filtered and concentrated. 
The crude reaction mixture was purified by flash chromatography on silica, eluting 
first with CH2Cl2/AcOEt 11:1 until the first fraction was collected and then changing 
to CH2Cl2/AcOEt 9:2 to collect the second fraction. The two fractions were 
concentrated and dried to give compound 7b (43 mg, 34%) and compound 8b (23 
mg, 22%). 
Compound 7b: 1H NMR (CD3OD) δ = 7.50 (d, J = 8.8 Hz, 4H), 7.49 (d, J = 16.0 Hz, 
2H), 7.38 (d, J = 8.4 Hz, 2H),7.31 (d, J = 16.0, 2H), 7.26 (d, J = 8.4 Hz, 2H),6.84 (d, J = 
8.8 Hz, 4H), 6.74 (s, 2H), 1.51 (s, 6H) ppm. 13C{1H} NMR (CD3OD) δ = 158.7, 152.9, 
141.5, 141.2, 136.3, 132.8, 131.7, 130.3, 128.7, 128.3, 119.4, 117.2, 115.7, 115.5, 53.4, 
13.6 ppm. UV-Vis (nm, CH2Cl2): 360, 595, 641; (nm, DMF): 378, 601, 652; (nm, H2O): 
379, 612, 673. Fluorescence (nm, DMF): 671; (nm, H2O): no emission peaks are 
observed. IR (CDCl3): 3608, 2971, 2927, 2854, 2127, 2099, 1603, 1512, 1256, 1199, 
1162 cm-1. MS calc. for C33H26BF2N5O2: 573.21. Found (ESI): m/z (%) = 572.29 (27) [M-
H]+. El. Anal. calc. for C33H26BF2N5O2: C, 69.12; H, 4.57; N, 12.21. Found C, 69.43; H, 
4.26; N, 12.10. 
Compound 8b: 1H NMR (CDCl3): δ = 7.52 (d, J = 16.4 Hz, 1H), 7.45 (d, J = 8.4 Hz, 2H), 
7.30 (d, J = 8.8 Hz 2H), 7.19 (d, J = 16.4 Hz, 1H), 7.17 (d, J = 8.8 Hz, 2H), 6.83 (d, J = 
8.4 Hz , 2H), 6.59 (s, 1H), 6.02 (s, 1H), 2.59 (s, 3H), 1.47 (s, 3H), 1.43 (s, 3H) ppm. 13C{1H} 
NMR (CDCl3) δ = 157.1, 155.0, 153.9, 142.7, 142.2, 141.2, 139.0, 138.3, 136.8, 133.1, 
131.8, 130.1, 129.5, 121.4, 119.8, 119.1, 117.9, 116.9, 116.0, 29.9, 15.1, 14.8. UV-Vis 
(nm, DMF): 346, 538, 576. Fluorescence (nm, DMF): 592. IR (CDCl3): 3584, 2966, 2928, 
2853, 2125, 2100. 1731, 1603, 1543, 1500, 1301, 1269, 1195, 1160 cm -1. MS calc. for 
C26H22BF2N5O: 469.19. Found (ESI): m/z (%) = 468.19 (100) [M-H]+. Anal. calc. for 
C26H22BF2N5O: C, 66.54; H, 4.73; N, 14.92. Found C, 66.23; H, 4.96; N, 14.70. 
 
8-(4-Azidophenyl)-1,7-dimethyl-3,5-bis-[2-(pyridin-2-yl)ethenyl]-4,4-difluoro-





 4-Azidophenyl-Bodipy (5) (100 mg, 0.27 mmol) and picolinaldehyde (104 µL, 1.09 
mmol, 4 eq.) were dissolved in anhydrous CH3CN (14 mL), with pyrrolidine (137 µL, 
1.64 mmol, 6 eq.) and acetic acid (94 µL, 1.64 mmol, 6 eq.). Activated molecular sieves 
(4 Å, 200 mg) were added. The mixture was stirred at 80 °C under N2 atmosphere. 
After few minutes a quick change in the color of the mixture is observed, from red to 
deep purple and TLC on alumina (eluent CH2Cl2), revealed the presence of a red spot 
(Rf = 0.88) and a blue one (Rf = 0.49). After 1 h the mixture was cooled to room 
temperature, filtered and diluted with CH2Cl2. The organic layer was washed with 
saturated NaHCO3 solution (3x25 mL), brine (35 mL), dried over anhydrous Na2SO4, 
filtered, and evaporated. The crude reaction mixture was purified by flash 
chromatography on alumina, eluting first with CH2Cl2/pet. et. 1:1 until the first 
fraction was collected and then changing to pure CH2Cl2 to collect the second 
fraction. The two fractions were concentrated and dried to give compound 7c (54 
mg, 37% yield) and compound 8c (22 mg, 18% yield). 
Compound 7c: 1H NMR (CDCl3) δ = 8.75 (d, J = 1.6 Hz, 2H), 8.55 (d, J dd, 4.7, 1.6 Hz, 
2H), 8.03 (d, J = 8.0 Hz, 2H), 7.77 (d, J = 16.4 Hz, 2H), 7.36-7.18 (m, 8H), 6.68 (s, 2H), 
1.52 (s, 6H) ppm. 13C{1H} NMR (CDCl3) δ = 167.8, 152.2, 150.2, 149.7, 149.6, 148.6, 
142.6, 141.3, 139.0, 134.9, 133.7, 133.1, 132.4, 132.2, 131.2, 129.0, 123.7, 123.5, 123.1, 
121.0, 119.8, 118.2, 14.9. UV-Vis (nm, CH2Cl2): 347, 575, 624. Fluorescence (nm, 
CH2Cl2): 643. IR (CDCl3): 3037, 2977, 2128, 2106, 1538, 1492, 1265, 1250 cm-1. MS calc. 
for C31H24BF2N7: 543.38. Found (ESI): m/z (%) = 544.30 (100) [M+H]+. El. Anal. calc. for 
C31H24BF2N7: C, 68.52; H, 4.45; N, 18.04. Found C, 68.74; H, 4.28; N, 18.10. 
Compound 8c: 1H NMR (CDCl3) δ = 8.62 (d, J = 5.1 Hz, 1H), 7.98 (d, J = 16.5, 1H), 7.69 
(m, 2H), 7.36-7.27 (m, 3H), 7.20-7.16 (m, 3H), 6.65 (s, 1H), 6.05 (s, 1H), 2.61 (s, 3H), 
1.48 (s, 3H), 1.45 (s, 3H). 13C{1H} NMR (CDCl3) δ = 154.2, 148.8, 142.8, 140.8, 140.2, 
135.4, 134.2, 130.4, 128.8, 121.8, 121.7, 121.1, 120.7, 118.8, 117.1, 28.7, 13.8. UV-Vis 
(nm, CH2Cl2): 322, 522, 560. Fluorescence (nm, CH2Cl2): 568. IR (CDCl3): 2927, 2856, 
2129, 2102, 1543, 1500, 1195, 1160. MS calc. for C25H21BF2N6: 454.19. Found (ESI): m/z 
(%) = 455.17 (100) [M+H]+. Anal. calc. for C25H21BF2N6: C, 66.10; H, 4.66; N, 18.50. 





4-Azidophenyl-Bodipy (5) (60 mg, 0.16 mmol) and 4-formyl-benzoic acid (96 mg, 
0.64 mmol, 4 eq.) were dissolved in anhydrous CH3CN (10 mL), with pyrrolidine (133 
μL, 1.6 mmol, 10 eq.) and acetic acid (55 μL, 0.96 mmol, 6 eq.). Activated molecular 
sieves (4 Å, 200 mg) were added. The mixture was stirred at 80 °C under N2 
atmosphere. After few minutes a quick change in the color of the mixture is observed, 
from red to dark purple and TLC on silica (CH2Cl2/MeOH 6:1), revealed the presence 
of a blue spot (Rf = 0.50). The reaction was monitored by TLC and after 1 h was cooled 
to room temperature, filtered and the resulting solution diluted with a methanolic 
solution of HCl (0.5 M, 10 mL). The solution was concentrated and the crude reaction 
mixture was purified by flash chromatography (CH2Cl2/MeOH 10:1 + 1% CH3COOH, 
to afford compound 7d (30 mg, 29%). 
Compound 7d: 1H NMR (DMSO, 400 MHz) δ = 8.02 (d, J = 8 Hz, 4H), 7.71 (d, J = 8 
Hz, 4H), 7.66-7.60 (m, 4H), 7.51 (d, J = 8 Hz, 2H), 7.34 (d, J = 8 Hz, 2H), 7.06 (s, 2H) 
ppm; 13C{1H} NMR (DMSO, 100 MHz) δ = 172.27, 152.0, 144.8, 142.2, 138.8, 136.5, 
130.6, 130.2, 130.0, 129.6, 129.1, 128.9, 128.3, 127.0, 119.36, 118.9, 21.2 ppm; Anal. 
calc. for C35H26BF2N5O4: C, 66.79; H, 4.16; N, 11.13. Found C, 66.54; H, 4.38; N, 11.27. 
 
Preparation of modified carbon nanotubes 9.  
 
 
Oxidized carbon nanotubes (ox-MWCNT):29 A mixture of commercially available 
MWCNTs (Sigma-Aldrich, O.D. x L. = 6-9 nm x 5 µm, carbon > 95%, CoMoCat©) (507 
mg), H2SO4 96% (15 mL) and HNO3 65% (5 mL) was stirred at 100°C for 30'. The 
suspension was then diluted with cold water and filtered on Teflon filter (Wathmann, 
pore size 0.2 μm). The residue was washed with water to neutral pH. The solid was 
dried at 80 °C under vacuum for 12 h affording a black powder (237 mg). IR (KBr, 
Figure 33): 3434, 2913, 2845, 1706, 1627, 1577, 1381, 1102 cm-1. Elem. Anal. C, 78.8; 
N, 0.0; H, 0.37.  
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Figure 33. IR spectrum (KBr) of ox-MWCNTs 
 
 
Figure 34. Raman spectra (µ-Raman, 514.5 nm) on pristine MWCNTs (black line) and 
ox-MWCNTs (red line) 
The Raman spectra (Figure 34) show two main bands: the G band (1590 cm-1) and the 
D band (1350 cm-1). For pristine MWCNTs IG/ID = 0.85 while ox-MWCNTs IG/ID = 0.80. 




Figure 35.TEM image of ox-MWCNTs and statistical distribution of their lengths 
The TEM analysis of the Ox-MWCNTs shows the integrity of the CNTs scaffold and 
their reduced lengths (from 5 µm of the pristine MWCNT). 
 
Figure 36. Uv absorption spectrum of ox-MWCNTs (H2O, 0.02 mg mL-1) and an 
image of a solution in water (2 mg mL-1) 
46 
 
Tour reaction (synthesis of ox-MWCNTs-9-SiMe3): The oxidized carbon nanotubes 
(20 mg) was dispersed in water (5 mL), the pH was adjusted to 11 with ammonia, 4-
(2-(trimethylsilyl)ethynyl)aniline (76 mg, 0.40 mmol) and isopentylnitrite (66 µL, 0.49 
mmol) were added and the dispersion was sonicated for 10'. The mixture was stirred 
at 80 °C under N2 atmosphere for 48 h. The reaction mixture was then filtered on 
teflon filter (Whatmann, pore size 0.2 μm) washing with water, MeOH, and acetone 
until a colorless filtrate was observed for each solvent. The solid residue was dried 
under vacuum affording a black powder (27 mg). The IR spectrum shows a net peak 
at 2155 cm-1 related to the presence of the -CC-SiMe3 group. IR (KBr, Figure 37): 
3396, 2913, 2155, 1724, 1582, 1389, 1247, 1174 cm-1.  
 
Figure 37. IR spectrum (KBr) of ox-MWCNTs-9-SiMe3 
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Compound 9 (desilylation procedure): ox-MWCNTs-9-SiMe3 (25 mg) was dissolved 
in DMF (20 mL), the mixture was sonicated for 10', and tetrabutylammonium fluoride 
1.0 M in THF (1 mL) was slowly added to the dispersion at 0 °C. The reaction mixture 
was stirred for 2h and filtered on teflon filter (Whatmann, pore size 0.2 μm) washing 
with DMF, CH2Cl2, and acetone until a colorless filtrate was observed for each solvent. 
The solid residue was dried under vacuum affording a black powder (24 mg). IR (KBr, 
Figure 38): 3422, 2956, 2922, 2870, 1729, 1574, 1384, 1169 cm-1. 
 
Figure 38. IR spectrum (KBr) of ox-MWCNTs-9 
A TGA-MS analysis was performed on the decorated ox-MWCNTs after the Tour 
reaction (ox-MWCNTs-9-SiMe3) and after the desilylation procedure (ox-MWCNTs-
9) to evaluate the amount of chemically accessible CC-SiMe3 groups present on the 
ox-MWCNTs (Figure 39).  
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Figure 39. TGA-MS analysis of MWCNTs-9-SiMe3 and ox-MWCNTs-9. Upper graph: 
temperature range and Ion current of ion m/z 73. Lower graph: TG and ΔTG lines 
The TGA analysis showed a 6.5 % weight loss of ox-MWCNTs-9-SiMe3 with respect 
to the desilylated sample in the temperature range 80-343 °C. The temperature range 
was chosen according to the presence of the ion m/z 73 (Me3Si group) in the mass 
spectrum (see upper graph in Figure 39). The abundance of the ion m/z 73 is higher 
from 80 to 174 °C but it is persistent (even if lower than before) up 350 °C. The limit 
of the temperature range (343 °C) was chosen when the ΔTG lines of the two sample 
crossed, suggesting the same thermal behavior. A weight loss of 6.5 % corresponds 
to the presence of 0.9 mmol of SiMe3 per gram of material, a value in accord with the 
functionalization degree found with the ICP data obtained for compound 10 and 11. 
 
Compound 10 (coupling between 4-Azidophenyl-Bodipy (5) and modified carbon 
nanotubes 9). Modified carbon nanotubes 9 (23 mg) were dissolved in anhydrous 
DMF (3 mL) and sonicated for 10', 4-Azidophenyl-Bodipy (27 mg, 0.074 mmol) and 
CuIP(OEt)3 (3 mg, 0.008 mmol) were added to the suspension. The mixture was 
49 
stirred at 70 °C under N2 atmosphere for 48 h. Every 16 h an additional amount of 
catalyst (3 mg, 0.008 mmol) was added and the mixture was sonicated for 5 min. The 
reaction mixture was then filtered on teflon filter (Anodisc, pore size 0.2 μm) washing 
with DMF and AcOEt until a colorless filtrate was observed for each solvent. The solid 
residue was dried under vacuum affording the compound 10 as a black powder (15 
mg). UV-Vis (nm, DMF): 506. Fluorescence (nm, DMF): 514. IR (KBr): 3398, 2914, 1723, 
1581, 1543, 1510, 1401, 1306, 1192, 1155, 1027, 979 cm-1. ICP analysis: B, 12.4 mg/g. 
 
Compound 11 (coupling between Bodipy 8c and modified carbon nanotubes 9). 
Modified carbon nanotubes 9 (7 mg) together with Bodipy 8c (5 mg, 0.011 mmol) 
and CuIP(OEt)3 (1 mg, 0.003 mmol) as catalyst were dispersed in anhydrous DMF (4 
mL), the suspension was sonicated for 5' and N,N-diisopropylethylamine (5 µL, 0.02 
mmol) was added. The mixture was stirred vigorously at 60 °C under N2 atmosphere 
for 48 h. Every 16 h the mixture was sonicated for 5 min. The reaction was then cooled 
to room temperature, diluted with (i-Pr)2O (50 mL), and centrifuged for 5' at 1400 g. 
Then the centrifugation and dispersion passages were repeated for additional three 
times, with fresh (i-Pr)2O and sonication each time, to completely remove unreacted 
materials. The last supernatant appear clear and colorless. The precipitate was dried 
under vacuum to obtain carbon nanotubes 11 as a dark powder (15.3 mg). UV-Vis 
(nm, DMF): 571. Fluorescence (nm, DMF): 595. IR (KBr): 3445, 2963, 2918, 1591, 1514, 
1434, 1157, 1110, 987, 830 cm-1. ICP analysis: B, 6.2 mg/g 
 
Compound 12 (coupling between Bodipy 7b and modified carbon nanotubes 9). 
Modified carbon nanotubes 9 (18 mg) together with Bodipy 7b (26 mg, 0.045 mmol) 
and CuIP(OEt)3 (2 mg, 0.006 mmol) as catalyst were dispersed in anhydrous DMF (3 
mL), the mixture was sonicated for 10' and stirred at 70°C under N2 atmosphere for 
48h. Every 16 h an additional amount of catalyst (2 mg, 0.006 mmol) was added and 
the mixture was sonicated for 5'. The reaction mixture was then filtered on teflon 
filter (Whatmann, pore size 0.2 μm) and washed with DMF, i-PrOH, and acetone until 
a colorless filtrate was observed for each solvent. The residue was sonicated 10' and 
the filtration with acetone was repeated to ensure the absence of unreacted Bodipy. 
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The solid residue was dried under vacuum affording the compound 12 as a blue-
black powder (15 mg). UV-Vis (nm, DMF): 653. Fluorescence (nm, DMF): 668. 
 
 
Synthesis of ox-MWCNT modified carbon nanotubes 14: Oxidized carbon 
nanotubes, (40 mg) and 4-azidoaniline (13) (93 mg, 0.69 mmol) were dispersed in 
anhydrous DMF (5 mL), isopentylnitrite (93 L, 0.69 mmol) was added and the 
dispersion was sonicated for 10'. The mixture was stirred vigorously at 60°C under N2 
atmosphere for 24 h. The reaction was then cooled to room temperature and diluted 
with (i-Pr)2O (100 mL). The black mixture was centrifuged for 5 minutes at 1400g, the 
supernatant was removed and the precipitate was redisperded in (i-Pr)2O and 
sonicated for 5 minutes. The centrifugation and dispersion process was repeated for 
f our times, with fresh (i-Pr)2O to completely remove unreacted products. Finally, the 
precipitate was dried under vacuum to obtain carbon nanotubes 14 as a black 
powder (48 mg). IR (KBr): 3411, 2918, 2112, 1720, 1580, 1502, 1379, 1261, 1015. Elem. 
Anal. C, 72,6; N, 8,15; H, 1,74.  
The TGA analysis, performed in comparison with a sample of ox-MWCNT showed a 
significant loss of weight in the 130-200 °C range assigned to the loss of N2 (Figure 
40). 
 
Figure 40. TGA analysis of ox-MWCNT and compound 14 
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Compound 16: Modified carbon nanotubes 14 (7 mg) were dispersed in anhydrous 
DMF (4 mL) with BOC-propargilamine (15) (15 mg, 0.096 mmol) and CuI·P(OEt)3 (5 
mg, 0.014 mmol). The suspension was sonicated for 10' and N,N-
diisopropylethylamine (10 L, 0.06 mmol) was added. The suspension was stirred 
vigorously at 60°C under N2 atmosphere for 48 h. Every 16 h the mixture was 
sonicated for 5'. The reaction was then cooled to room temperature, diluted with (i-
Pr)2O (50 mL), and centrifuged for 5 minutes at 1400 g. Then, the centrifugation and 
dispersion process was repeated for additional three times, with fresh (i-Pr)2O to 
remove completely unreacted materials. The last supernatant liquid appeared clear 
and colorless. Finally, the solid was dried under vacuum to obtain carbon nanotubes 
16 as a dark-brown powder (8.5 mg). IR (KBr): 3385, 2913, 1689, 1578, 1505, 1364, 
1248, 1162, 1043, 836.  
A TGA-MS analysis, performed in comparison with ox-MWCNT, showed a loss of 
isobutene as revealed by the correspond ions present in the MS spectrum of the 
effluent gas. 
 
Figure 41. TGA-MS analysis of ox-MWCNT and compound 16 
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Compound 17: A solution of N,N'-dicyclohexylcarbodiimide (87 mg, 0.43 mmol) in 
anhydrous dichloromethane (1 mL), was added with 4-pentynoic acid (27 mg, 0.28 
mmol) followed by the addition of a solution of BODIPY A22,23 (94 mg, 0.2 mmol) in 
anhydrous dichloromethane (2 mL). Dimethylaminopyridine (4 mg, 0.03 mmol) was 
added and the reaction was stirred at room temperature under nitrogen. After 24 h 
the mixture was diluted with AcOEt (20 mL) and washed with water (2x10 mL), HCl 
0.5 M (2x20 mL), saturated NaHCO3 solution (2x30 mL), brine (2x30 mL). After drying 
over anhydrous Na2SO4 the solution was filtered and the solvent was evaporated. The 
crude reaction product was purified by flash chromatography on silica (Rf = 0.30) 
eluting with AcOEt/Hexane 1:2 to give compound 17 as an orange solid (100 mg, 
87% yield). UV-Vis (CH2Cl2): 501 nm. Fluorescence (CH2Cl2): 511 nm. 1H NMR (CDCl3) 
δ =7.67 (d, J = 8.6 Hz, 2H), 7.53 (s, 1H), 7.21 (d, J = 8.6 Hz, 2H), 5.97 (s, 2H), 2.63 (m, 
4H), 2.54 (s, 6H), 2.08 (m, 1H), 1.41 (s, 6H). 13C{1H} NMR (CDCl3) δ = 169.4, 155.4, 143.1, 
138.7, 131.6, 130.6, 128.7, 121.7, 120.0, 82.8, 69.8, 36.3, 33.9, 25.5, 24.9, 14.6.  
 
Figure 42. UV-Vis (black) and Fluorescence (red) spectrum of compound 17 
 
Compound 18: Compound 17 (120 mg, 0.29 mmol) and 2-pyridinecarboxaldehyde 
(108 L, 1.14 mmol) were dissolved in anhydrous CH3CN (10 mL), with pyrrolidine 
(142 L, 1.70 mmol) and acetic acid (97 L, 1.7 mmol). The condensation reaction was 
performed under molecular sieves. The mixture was stirred at 80°C under N2 
atmosphere. After few minutes a change in the color of the mixture is observed, from 









 = 511 nm
































red to dark blue. After 20 minutes the mixture was cooled to room temperature and 
diluted with AcOEt (30 mL). The organic layer was washed with saturated NaHCO3 
solution (3x30 mL), water (2x40 mL), brine (2x40 mL), dried over anhydrous Na2SO4 
and filtered, then the solvent was evaporated. The crude reaction product was 
purified by flash chromatography on silica (Rf = 0.34), eluting with CH2Cl2/EtOAc 10:3 
to give compound 18 (79 mg, 53% yield).  
Compound 18: 1H NMR (D6-DMSO) δ = 10.22 (s, 1H), 8.71 (d, J = 3.8 Hz, 2H), 8.12 (d, 
J = 16.4 Hz, 2H), 7.86-7.79 (m, 4H), 7.59 (d, J = 16.4 Hz, 2H ), 7.51 (d, J = 7.6, 2H), 7.38-
7.32 (m, 4H), 7.03 (s, 2H), 2.81 (t, J = 2.5 Hz, 1H) 2.58 (t, J = 7.1 Hz, 2H), 2.50 (m, 2H), 
1.50 (s, 6H). 13C{1H} NMR (D6-DMSO) δ = 170.2, 154.1, 152.1, 142.7, 140.7, 140.6, 
137.7, 136.2, 133.9, 129.2, 128.8, 125.0, 124.1, 122.1, 119.7, 119.4, 84.1, 72.0, 35.8, 14.9, 
14.4. UV-Vis (DMF): 349, 574, 623 nm. Fluorescence (DMF): 629. IR (CDCl3): 3685, 
2926, 2866, 2245, 1685, 1503, 1434, 1408, 1094. MS calc. for C36H30BF2N5O: 597.25. 
Found (ESI): m/z (%) = 596.33 (100) M-. 
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Modified carbon nanotubes 14 (10 mg) together with BODIPY 17 (7 mg, 0.017 mmol) 
and CuI·P(OEt)3 (1.4 mg, 0.004 mmol) were dispersed in anhydrous DMF (5 mL). The 
suspension was sonicated for 5' and N,N-diisopropylethylamine (5.8 L, 0.03 mmol) 
was added. The suspension was stirred at 60°C under N2 atmosphere for 48 h. Every 
16 h the mixture was sonicated for 5'. The reaction was then cooled to room 
temperature, diluted with (i-Pr)2O (50 mL), and centrifuged for 5 minutes at 1400 g. 
The centrifugation and dispersion steps were repeated for additional four times, with 
fresh (i-Pr)2O and sonication each time, to remove the unreacted materials 
completely. The last supernatant solution appeared clear and colorless. Finally, the 
solid was dried under vacuum to obtain carbon nanotubes 19 as a dark-brown 
powder (15 mg). UV-Vis (nm, DMF): 501. Fluorescence (nm, DMF): 513. IR (KBr): 3428, 
2913, 2845, 2095, 1588, 1510, 1381, 1303, 1186, 1135, 1046. ICP analysis: B, 9.76 mg/g. 
 
 
Figure 44. UV-Vis (black) and Fluorescence (red) spectrum of compound 19 
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Compound 20: Modified carbon nanotubes 14 (5 mg) together with Bodipy 18 (5 
mg, 0.010 mmol) and CuI·P(OEt)3 (1 mg, 0.003 mmol) as catalyst were dispersed in 
anhydrous DMF (3.5 mL), the suspension was sonicated for 5' and N,N-
diisopropylethylamine (5.8 L, 0.03 mmol) was added. The suspension was stirred at 
60°C under N2 atmosphere for 48h. Every 16h the mixture was sonicated for 5'. The 
reaction was then cooled to room temperature, diluted with (i-Pr)2O (50 mL), and 
centrifuged for 5' at 1400g. Then the centrifugation and dispersion passages were 
repeated for additional four times, with fresh (i-Pr)2O and sonication each time, to 
completely remove unreacted materials. The last supernatant appear clear and 
colorless. Finally the precipitate was dried under vacuum to obtain carbon nanotubes 
20 as a blue-black powder (5.8 mg). UV-Vis (nm, DMF): 350, 573, 627. Fluorescence 
(nm, DMF): 630. ICP analysis: B, 3.1 mg/g. 
 
Figure 45. UV-Vis (black) and Fluorescence (red) spectrum of compound 20. 










 = 630 nm  UV-Vis































UV-v  absorption and emission of compound 18
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Compound 22: Modified carbon nanotubes 14 (20 mg) together with alkyno-biotin 
21 (9.3 mg, 0.033 mmol) and CuI·P(OEt)3 (3 mg, 0.008 mmol) as catalyst were 
dispersed in anhydrous DMF (7 mL), the suspension was sonicated for 5' and N,N-
diisopropylethylamine (17 L, 0.09 mmol) was added. The suspension was stirred at 
60°C under N2 atmosphere for 48h. Every 16h the mixture was sonicated for 5'. The 
reaction was then cooled to room temperature, diluted with (i-Pr)2O (50 mL), and 
centrifuged for 5' at 1400g. Then the centrifugation and dispersion passages were 
repeated for additional two times, with fresh (i-Pr)2O and sonication each time, to 
completely remove unreacted materials. The last supernatant appear clear and 
colorless. The residue was then redispersed in water and washed by centrifugation 
for 20' at 15.000g four times to completely remove the biotin unbound to carbon 
nanotubes. Finally the precipitate was dried under vacuum to obtain carbon 
nanotubes 22 as a dark powder (14.4 mg). ICP analysis: S, 5.9 mg/g. 
 
 
Compound 23: Modified carbon nanotubes 14 (15 mg) together with alkyno-biotin 
21 (3.4 mg, 0.012 mmol), Bodipy 17 (5 mg, 0.012 mmol) and CuI·P(OEt)3 (2 mg, 0.006 
mmol) as catalyst were dispersed in anhydrous DMF (5 mL), the suspension was 
sonicated for 5' and N,N-diisopropylethylamine (8.6 L, 0.05 mmol) was added. The 
suspension was stirred at 60°C under N2 atmosphere for 48h. Every 16h the mixture 
was sonicated for 5'. The reaction was then cooled to room temperature, diluted with 
(i-Pr)2O (50 mL), and centrifuged for 5' at 1400g. Then the centrifugation and 
dispersion passages were repeated for additional three times, with fresh (i-Pr)2O and 
sonication each time, to completely remove unreacted materials. The last supernatant 
appear clear and colorless. The residue was then redispersed in water and washed by 
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centrifugation for 20' at 15.000g four times to completely remove the biotin unbound 
to carbon nanotubes. The precipitate was dried under vacuum to obtain carbon 
nanotubes 23 as a dark powder (16.2 mg). UV-Vis (nm, DMF): 500. Fluorescence (nm, 
DMF): 511. IR (KBr): 3422, 2918, 1580, 1099, 1255, 1630, 2846, 1382, 1537, 1510, 806. 
ICP analysis: B, 6.3 mg/g; S, 6.8 mg/g.  
 
Figure 46. UV-Vis (black) and Fluorescence (red) spectrum of compound 23. 
 
 
Compound 24. Modified carbon nanotubes 14 (30 mg) together with alkyno-biotin 
21 (10 mg, 0.035 mmol), Bodipy 18 (13 mg, 0.025 mmol) and CuI·P(OEt)3 (4 mg, 0.011 
mmol) as catalyst were dispersed in anhydrous DMF (7 mL), the suspension was 
sonicated for 5' and N,N-diisopropylethylamine (25 L, 0.14 mmol) was added. The 
suspension was stirred at 60°C under N2 atmosphere for 48h. Every 16h the mixture 
was sonicated for 5'. The reaction was then cooled to room temperature, diluted with 
(i-Pr)2O (50 mL), and centrifuged for 5' at 1400g. Then the centrifugation and 
dispersion passages were repeated for additional five times, with fresh (i-Pr)2O and 
sonication each time, to completely remove unreacted materials. The last supernatant 








UV-vis absorption and emission of compound 20

max emiss
































appear clear and colorless. The residue was then redispersed in water and washed by 
centrifugation 20' at 15.000g four times to completely remove the biotin unbound to 
carbon nanotubes. Finally the precipitate was dried under vacuum to obtain carbon 
nanotubes 24 as a dark powder (26.3 mg). UV-Vis (nm, DMF): 571, 623; (phosphate 
buffer pH 7.4): 572, 635. Fluorescence (nm, DMF): 630. ICP analysis: B, 1.0 mg/g; S, 1.6 
mg/g. 
 
Figure 47. UV-Vis (black) and Fluorescence (red) spectrum of compound 24. 
 
 
Compound 25 (DOX-loaded CNT): Nanotubes 24 (6 mg) were dissolved in a 
phosphate buffer solution 0.2 M at pH 7.4 (6 mL), the dispersion was sonicated for 5' 
and doxorubicin hydrochloride (4 mg, 0.007 mmol) was added. The mixture was 
stirred vigorously overnight at room temperature and in the dark. The reaction 
mixture was filtered on a Teflon filter (Whatmann, pore size 0.2 m) washing five 
times with phosphate buffer to completely remove the unbound doxorubicin 
(constant content of doxorubicin in the washing water, measured by UV-visible 
analysis). The solid residue was dried under vacuum to obtain DOX-loaded CNT 25 
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as a black-brown powder 8.1 mg. DOX loading (evaluated by difference from 
filtration waters): 0.60 g DOX/g CNT. UV-Vis (nm, phosphate buffer pH 7.4): 234, 254, 
481, 637; (nm, DMF): 349, 478, 496, 571, 623. 
 
 
Compound 26 (DOX-loaded CNT): Nanotubes 22 (6 mg) were dissolved in a 
phosphate buffer solution 0.2 M at pH 7.4 (6 mL), the dispersion was sonicated for 5' 
and doxorubicin hydrochloride (4 mg, 0.007 mmol) was added. The mixture was 
stirred vigorously overnight at room temperature and in the dark. The reaction 
mixture was filtered on a Teflon filter (Whatmann, pore size 0.2 m) washing six times 
with phosphate buffer to completely remove the unbound doxorubicin (constant 
content of doxorubicin in the washing water, measured by UV-visible analysis). The 
solid residue was dried under vacuum to obtain DOX-loaded CNT 26 as a black-
brown powder (7.9 mg). DOX loading (evaluated by difference from filtration waters): 
0.57 g DOX/g CNT. UV-Vis (nm, phosphate buffer pH 7.4): 233, 253, 481, 493. 
 
Figure 48. UV spectrum of compound 26 
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Compound 27 (DOX-loaded CNT): Nanotubes 14 (6 mg) were dissolved in a 
phosphate buffer solution 0.2 M at pH 7.4 (6 mL), the dispersion was sonicated for 5' 
and doxorubicin hydrochloride (4.2 mg, 0.007 mmol) was added. The mixture was 
stirred vigorously overnight at room temperature and in the dark. The reaction 
mixture was filtered on a Teflon filter (Whatmann, pore size 0.2 m) washing six times 
with phosphate buffer to completely remove the unbound doxorubicin (constant 
content of doxorubicin in the washing water, measured by UV-visible analysis). The 
solid residue was dried under vacuum to obtain DOX-loaded CNT 27 as a black-
brown powder (9.6 mg). DOX loading (evaluated by difference from filtration waters): 
0.54 g DOX/g CNT. UV-Vis (nm, phosphate buffer pH 7.4): 233, 254, 472. 
 
Figure 49. UV spectrum of compound 27. 
 
3.3 Biological assays 
Cells cultures 
Breast cancer cells (MCF-7), colon cancer cells (HT29) and prostate cancer cells (PC3) 
were routinely grown in 60 mm plates and maintained in monolayers to 80% 
confluence using DMEM supplemented with 10% fetal bovine serum, 1% penicillin–
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streptomycin and 1% glutamine solutions, in a 5% CO2 controlled humidified 
atmosphere at 37°C. 
 
Flow Cytometric Analysis 
MCF-7, PC3 and HT29 cancer cells were grown in 35mm dishes until 60% of 
confluence and treated with 10 g/ml of fluorescent carbon nanotubes for 90 
minutes at 37°C. Then, cells were detached by trypsinization and resuspended in 
DMEM medium. Cells were collected by centrifugation and washed with PBS before 
flow cytometric analysis using a FACSCanto flow cytometer (Becton-Dickinson). 
 
Analysis of carbon nanotubes cells internalization with confocal microscopes 
To evaluated the carbon nanotubes incorporation in MCF-7 cells, 0.5x106 cells were 
plated on 35-mm dishes containing glass cover slips on the bottom and growth at 
37°C under controlled atmosphere for 24 hours. Then, BODIPY decorated carbon 
nanotubes (10 g/ml, final concentration) were added to cell cultures, and stored at 
37°C for three hours. After this time, cells were extensively washed with PBS to 
remove the non-internalized nanotubes, and then cells were fixed in 3% 
paraformaldehyde for 30 min at room temperature before the analysis with the 
confocal fluorescence microscope. The analysis was made using a Leica TCS SP5 
confocal scanning microscope (Leica Microsystems, Mannheim, Germany), equipped 
with an argon laser source and a Leica Plan Apo 639 oil immersion objective. 
 
MTT test (toxicity tests) 
Procedure 
MCF-7 breast cancer cells were incubated for 24 hours in the presence of the test 
compounds. After this time, viability of cells was evaluated using MMT assay. Values 
obtained were normalized with respect to control experiments. Data reported 
represent the mean value S.E.M. (n = 3).  
Experimental details 
MCF-7 cells were grown in the presence of Dulbecco’s modified Eagle’s medium 
supplemented with 10% fetal bovine serum (FBS), 1% glutamine, and 1% penicillin-
streptomycin, at 37 °C in controlled atmosphere with 5% CO2. For the experiments, 
cells were seeded at a density of 80000 cells per well in P35 mm well plates; the day 
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after, compounds were added to growth medium and cells stored at 37 °C in 5% CO2 
for 24 h. After this time, the growth medium was removed and plates extensively 
washed with PBS. Then the media were replaced with medium containing 0.5 mg/mL 
of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) and the cells 
were incubated for 1 h at 37 °C in 5% CO2. Finally, the number of viable cells was 
quantified by the estimation of their dehydrogenase activity, which reduces MTT to 
water-insoluble formazan. Growth medium was removed and substituted with 1 ml 
of DMSO to dissolve the formazan produced. The quantification was carried out 
measuring the absorbance of samples at 570 nm. 
 
3.4 UV and fluorescence spectra:  




Compound 7b: UV spectra 
 
 





Compound 8b: UV Spectra 
 
 
Compound 8b: Fluorescence spectra 
 




Compound 8c: fluorescence spectra 
 
 




3.5 NMR spectra:  
Compound 7b 1H NMR 
 
 
Compound 8b 1H NMR 
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Compound 7c 1H NMR 
 
 
Compound 8C 1H NMR 
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Compound 7d 1H NMR 
 
 
Compound 7b 13C NMR 
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Compound 8b 13C NMR 
 
 











Combined experimental and theoretical study of efficient and ultrafast energy 
transfer in a molecular dyad24 
It has been characterized the dynamics and the efficiency of electronic energy 
transfer (EET) in a newly synthesized molecular dyad, composed of a 
styryl-pyridinium donor and a BODIPY acceptor (Figure 50). The kinetics of the 
process has been studied with femtosecond transient absorption spectroscopy in 
different solvents. In all the analyzed media EET is quantitative and very fast, as we 
find that almost 70% of the overall excitation energy is transferred from the donor to 
the acceptor on a subpicosecond time scale. The experimental measurements have 
been supported by a theoretical analysis; the electronic couplings between the donor 
and acceptor moieties have been calculated at the (TD)DFT [Time-dependent density 
functional theory] level and complemented by a conformational analysis of the full 
dyad. The computed energy transfer times are in good agreement with the 
experimental values; this allowed us to verify the correctness of the Förster equation, 
demonstrating that, although EET in the examined system occurs on an ultrafast time 
scale, the approximations introduced in the case of the weak coupling regime remain 
valid. 
 
Figure 50. Evolution Associated Decay Spectra obtained from global analysis of the 
transient data of the bichromophore in chloroform 
Synthetic procedure 
The synthesis of the bichromophore was realized according to the following scheme: 
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Synthesis of 1-But-3-ynyl-4-[2-(4-diethylamino-phenyl)-vinyl]-pyridinium iodide 
(29). 4-iodo-1-butyne (240 mg, 1.33 mmol) and 4-[2-[4-
(diethylamino)phenyl]ethenyl]-pyridine 28 (168 mg, 0.67 mmol) were dissolved in 
anhydrous CH3CN (12 ml). The mixture was refluxed under N2 atmosphere. The 
reaction was monitored by TLC (CH2Cl2/MeOH 10:1, Rf = 0.38). After 96 h the solvent 
was evaporated and the reaction product was purified by flash chromatography, 
eluting first with CH2Cl2/MeOH 50:1 and then CH2Cl2/MeOH 25:1, to afford 
compound 29 (232 mg, 80% yield). 
1HNMR (300MHz, CDCl3): δ = 8.85 (d, 3J=6.9Hz, 2H), 7.82 (d, 3J=6.9Hz, 2H), 7.63 (d, 
3Jtrans=15.9Hz, 1H), 7.53 (d, 3J=9.0Hz, 2H), 6.85 (d, 3Jtrans=15.9Hz, 1H), 6.64 (d, 3J=9.0Hz, 
2H), 4.79 (t, 3J=6.0Hz, 2H), 3.41 (q, 3J=7.2Hz, 4H), 2.95 (td, 3J=6.0Hz, 4J=2.7Hz, 2H), 
2.12 (t, 4J=2.7Hz, 1H), 1.19 (t, 3J=7.2Hz, 6H) ppm; UV-Vis (CH2Cl2) λmax = 533nm; 
Fluorescence (CH2Cl2) λmax = 608 nm; MS (ESI): m/z (%) = 305.24 (100) [M-I-]+, 732.52 
(14) [M+(M-I-)]+; Elemental analysis calcd for C21H25IN2: N 6.48, C 58.34, H 5.83; found 
N = 6.08, C 57.97, H 5.89. 
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Synthesis of bi-chromophore. Compound 7 (126 mg, 0.23 mmol) and compound 29 
(124 mg, 0.29 mmol, 1.25 equiv.) were dissolved in anhydrous THF (5 mL). Then N,N-
diisopropylethylamine (81.1 μL, 60.2 mg, 0.46 mmol, 2 equiv.), and CuI·P(OEt)3 (28 
mg, 0.08 mmol, 0.3 equiv.) were added. The mixture was stirred at r.t. in N2 
atmosphere for 72h and it was monitored by TLC (CH2Cl2/MeOH 10:1). Then the 
solvent was evaporated and the crude was purified by flash chromatography on 
alumina (activity V, pH 7) eluting with CH2Cl2/MeOH 50:1 (Rf=0.22) to give the product 
as a dark powder (126 mg, 55% yield). 1H NMR (400MHz, CDCl3): δ = 9.03 (s, 1H), 9.01 
(d, 3J = 6.8 Hz, 2H), 8.04 (2H, 3J = 8.4 Hz, 2H), 7.73 (d, 3Jtrans  = 16.4 Hz, 2H), 7.68 (d, 3J 
= 6.8 Hz, 2H), 7.65 (d, 3J = 7.2 Hz, 4H), 7.54 (d, 3Jtrans = 15.6 Hz, 1H), 7.49 (pd, 4H), 7.40 
(pt, 4H), 7.32 (m, 4H), 6.77 (d, 3Jtrans = 15.6 Hz, 1H), 6.67 (pt, 4H), 5.13 (t, 3J = 7.0 Hz, 
2H), 3.70 (t, 3J = 7.0 Hz, 2H), 3.43 (q, 3J = 7.1 Hz, 4H), 1.49 (s, 6H), 1.22 (t, 3J = 7.1 Hz, 
6H) ppm; 13C NMR (100MHz, CDCl3): δ =  154.6 (s), 153.0 (s), 150.5 (s), 143.6 (s), 143.2 
(d), 142.7 (s), 142.0 (d), 137.4 (s), 137.1 (s), 136.6 (d), 136.5 (d), 133.2 (d), 131.2 (d), 
130.2 (d), 129.0 (d), 128.8 (d), 127.6 (d), 122.8 (s), 122.1 (d), 121.4 (s), 120.9 (d), 119.2 
(s), 118.1 (d), 115.4 (d), 111.6 (d), 58.4 (t), 44.7 (t), 27.7 (t), 15.1 (q), 12.6 (q) ppm; UV-
Vis (CH2Cl2) λmax = 350 nm, 533 nm, 574nm, 628nm; Fluorescence (CH2Cl2) λmax =  643 
nm; IR (CDCl3) : ν = 3005 (w), 2974 (w), 2930 (w), 1710 (s), 1574 (s), 1541 (m), 1524 (s), 
1508 (m), 1439 (m), 1411 (m), 1364 (s), 1325 (w), 1223 (m), 1164 (m), 1153 (m) cm -1; 
MS (ESI): m/z (%) = 846.47 (100) [M-I-]+. 
 
Appendix B 
A Hetero-Bifunctional Spacer for the Smart Engineering of Carbon-Based 
Nanostructures10 
It has been performed the synthesis of a linear hetero-functional crosslinker featuring 
a cleavable disulfide moiety for the covalent anchoring of a wide range of thiol 
end-capped (bio)molecules and, through a clickable terminal acetylene group, the 
CuAAC reaction at the surface of phenylazido-decorated carbon-based 
nanostructures. The bio-orthogonal character of the click reaction makes it highly 
desirable for conjugating CNTs and biomolecules.50,51 The adopted methodology 
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generated multifunctional CNT platforms, in which disulfide bond cleavage, 
operating through sulfhydryl-containing molecules, occurred with the controlled 
release of a pyridine dye, the concentration of which was proportional to the extent 
of cleavage or conjugation by an incoming thiol end-capped molecule (Figure 51). 
As a result, the cleavage/functionalisation scheme provided a useful tool for the 
chemical linkage of a wide range of thiol-terminating probes to the carbon 
nanomaterial surface, and precise functionalization loading was simply assessed by 
UV/Vis measurements. Controlled CNT hetero-decoration through a one-step CuAAC 
reaction with an acetylene mixture composed of the bifunctional linker and an 
acetylene fluorescence dye (BODIPY derivative) was used to impart multifunctionality 
on the final carbon nanohybrid.  
 
Figure 51. The single-walled CNTs doubly decorated and the release of pyridine dye 
upon exchange with the HS-terminating amino acid. 
This approach generated optically traceable nanocarriers, the conjugation of which 
with sulfhydryl-containing (bio)molecules was allowed through simple ligand 
exchange at the disulfide bridge. Most importantly, each functionalization and 
post-derivatization step could be precisely followed by spectroscopic measurements 
(UV/Vis) of the reaction solutions by monitoring the release of a pyridine dye. A 
morphological study of the as-prepared hetero-decorated nanohybrids provided 
interesting insights into the ultimate distribution of the functional groups at the 
nanomaterial surface, as a consequence of the regiochemical attachment of radical 
species generated from aryldiazonium intermediates. 
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